Portfolio (Quarterly)
Guide ↗
Ishara Investments LP
· CIK 0002111609| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | SLN | SILENCE THERAPEUTICS PLC | Healthcare | 240,000.0 | $1.5M | 1.67% | NEW | — | $6.08 | +2.6% |
| 22 | EWTX | EDGEWISE THERAPEUTICS INC | Healthcare | 58,000.0 | $1.4M | 1.65% | NEW | — | $24.82 | +31.7% |
| 23 | BEAM | BEAM THERAPEUTICS INC | Healthcare | 50,000.0 | $1.4M | 1.58% | NEW | — | $27.72 | -0.2% |
| 24 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 160,000.0 | $1.3M | 1.50% | NEW | — | $8.18 | +3.4% |
| 25 | APLS | APELLIS PHARMACEUTICALS INC | Healthcare | 50,000.0 | $1.3M | 1.44% | NEW | — | $25.12 | +63.3% |
| 26 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 70,000.0 | $1.2M | 1.32% | NEW | — | $16.51 | +16.9% |
| 27 | RARE | ULTRAGENYX PHARMACEUTICAL IN | Healthcare | 50,000.0 | $1.1M | 1.31% | NEW | — | $23.00 | +1.6% |
| 28 | — | ASCENDIS PHARMA A/S | — | 5,000.0 | $1.1M | 1.22% | NEW | — | $213.24 | — |
| 29 | — | NEWAMSTERDAM PHARMA COMPANY | — | 30,000.0 | $1.1M | 1.20% | NEW | — | $35.08 | — |
| 30 | LXRX | LEXICON PHARMACEUTICALS INC | Healthcare | 880,000.0 | $1.0M | 1.16% | NEW | — | $1.15 | +93.9% |
| 31 | — | BIOHAVEN LTD | — | 88,000.0 | $994K | 1.14% | NEW | — | $11.29 | — |
| 32 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 24,000.0 | $989K | 1.13% | NEW | — | $41.21 | +117.5% |
| 33 | NKTR | NEKTAR THERAPEUTICS | Healthcare | 20,000.0 | $846K | 0.97% | NEW | — | $42.28 | +62.2% |
| 34 | IMTX | IMMATICS N.V | Healthcare | 80,000.0 | $840K | 0.96% | NEW | — | $10.50 | +5.3% |
| 35 | AGIO | AGIOS PHARMACEUTICALS INC | Healthcare | 30,000.0 | $817K | 0.93% | NEW | — | $27.22 | +5.8% |
| 36 | IMVT | IMMUNOVANT INC | Healthcare | 30,000.0 | $763K | 0.87% | NEW | — | $25.42 | +34.3% |
| 37 | OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | 30,000.0 | $750K | 0.86% | NEW | — | $25.00 | -43.8% |
| 38 | ARQT | ARCUTIS BIOTHERAPEUTICS INC | Healthcare | 12,000.0 | $348K | 0.40% | NEW | — | $29.04 | -27.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
97.3%
Industrials
2.7%